ARCT
Arcturus Therapeutics Holdings Inc
NASDAQ: ARCT · HEALTHCARE · BIOTECHNOLOGY
$8.40
-5.30% today
Updated 2026-04-29
Market cap
$238.75M
P/E ratio
—
P/S ratio
2.91x
EPS (TTM)
$-2.40
Dividend yield
—
52W range
$6 – $24
Volume
0.5M
Arcturus Therapeutics Holdings Inc (ARCT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-80.20%
Operating margin
-435.10%
ROE
-28.90%
ROA
-15.50%
Debt/equity
0.10x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | — | $-3.93M | — | — | — |
| 2012 | — | $-1.58M | — | — | — |
| 2013 | $0.00 | $-10.55M | — | — | — |
| 2014 | $0.00 | $-32.83M | — | — | — |
| 2015 | $6.14M | $-19.45M | 99.17% | -320.92% | -316.86% |
| 2016 | $20.38M | $-24.60M | 98.56% | -123.48% | -120.71% |
| 2017 | $13.00M | $-10.90M | 96.85% | -80.72% | -83.87% |
| 2018 | $15.75M | $-21.79M | -7.80% | -138.46% | -138.29% |
| 2019 | $20.79M | $-25.99M | 100.00% | -122.72% | -125.02% |
| 2020 | $9.54M | $-72.15M | -486.50% | -749.81% | -756.35% |
| 2021 | $12.36M | $-203.67M | 100.00% | -1,641.33% | -1,647.98% |
| 2022 | $205.75M | $9.35M | 100.00% | 5.92% | 4.54% |
| 2023 | $157.75M | $-29.73M | 100.00% | -49.58% | -18.84% |
| 2024 | $138.39M | $-80.94M | 100.00% | -69.13% | -58.49% |
| 2025 | $67.22M | $-65.78M | 95.50% | -111.51% | -97.86% |